Navigation Links
Differences between women and men with a primary psychotic episode analyzed in a Ph.D. thesis
Date:6/30/2010

This release is available in Spanish.

Schizophrenia is a heterogeneous disease, due to the fact that the reasons for its onset are varied, as are the reactions of patients who suffer from it. Some experts relieve that gender is an important factor in this heterogeneity. Ms Ana Cataln has presented her PhD thesis at the University of the Basque Country (UPV/EHU) on this topic, entitled Differences in the prognostic and clinical presentation as a function of gender amongst patients with a primary psychotic episode. She concluded that there are differences between men and women in this matter and that should be taken into account, but there is no evidence to suggest that sex totally conditions this illness.

In order to carry out her thesis, Ms Cataln designed an observational study and limited it to the primary psychotic episode. She analysed 231 patients, selected after establishing the criteria required thereof. For two years she studied the progress of these patients with a primary psychotic episode, evaluating gender solely as a biological feature, i.e. leaving aside its social and cultural connotations.

Later in women

Based on the observation of these patients, according to Ms Cataln, women with a primary psychotic episode in general show symptoms of the illness later and have a greater probability of being married and/or living with their partner and/or children. Moreover, in the case of women it is more common to suffer an acute form of psychosocial stress in the year prior to the onset of the illness. Also, on applying the Cannon-Spoor subscale, which measures the promorbid or prior to the illness adjustment, women obtain better results in late adolescence, adult age and in general. That is, during the lifetime previous to the onset of the first symptoms, appropriately complying with expectations in accord with each age range.

The author of the thesis also used the scale known as PANSS in order to analyse the clinical progress of the patients over the two years the research lasted; this scale is used to measure the gravity of the symptoms of patients with schizophrenia. As the scale shows, differences between the two sexes are, with an occasional exception, scant in the progress at the basal phase of the illness.

Thus, concluded Ms Cataln, the sex does not turn out to be a decisive prognostic factor in the progress of primary psychotic episodes. However, there are differences produced between men and women as regards the characteristics of the psychotic crisis episodes (clinical phenotype) and the author of the thesis underlines that these should be taken into consideration by the doctor.


'/>"/>

Contact: Amaia Portugal
a.portugal@elhuyar.com
34-943-363-040
Elhuyar Fundazioa
Source:Eurekalert

Related medicine news :

1. Chinese systemic lupus erythematosus data reveal differences in epidemiology across continents
2. Genealogy may affect clinical differences in systemic lupus erythmatosus patients
3. Vast geographic differences found in drug spending under Medicare
4. Survey highlights major Canada-US differences in people in middle age
5. Genetic differences may influence joint pain among women taking lifesaving breast cancer drugs
6. Regional differences in C-section rate not a result of maternal request: UBC study
7. Dyslexia Linked to Differences in Brain Circuitry
8. Population health plays a bigger role in geographic differences in Medicare spending
9. Exploring gender differences in colorectal cancer screenings
10. Differences in language circuits in the brain linked to dyslexia
11. Gender Differences Show in Risk of Narcotic Abuse
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... ... April 24, 2017 , ... ... individuals with HIV because it is not known to have significant interactions with ... effects to both lower cholesterol levels and dampen inflammation in the bloodstream. , ...
(Date:4/24/2017)... ... April 24, 2017 , ... Labs often perform the ... for lab operators and management to assess these processes with a critical eye—particularly ... unnecessary actions. , Created with the help of both internal and external ...
(Date:4/24/2017)... ... April 24, 2017 , ... “Reflections of God’s Work”: ... “Reflections of God’s Work” is the creation of published author, Jerri Broglin, a survivor ... , “I believe this a great eye-opener for those searching for answers, as ...
(Date:4/24/2017)... ... April 24, 2017 , ... Miami Periodontist ... 2017 Oral Reconstruction Foundation’s 2017 Symposium on Tissue Regeneration and Implant Dentistry held ... its annual Global Symposium at the Fontainebleau Hotel located in Miami Beach, FL. ...
(Date:4/24/2017)... ... April 24, 2017 , ... Anaconda ... generation neuro-thrombectomy systems for the treatment of Acute Ischemic Stroke (AIS), today announced ... device as the product advances towards regulatory and clinical phases. , "This is ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... April 20, 2017 Research and Markets ... Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key ... to their offering. ... global pharmacogenomics market was valued at US$ 7,167.6 Mn in ... 2024, expanding at a CAGR of 5.6% from 2016 to ...
(Date:4/20/2017)... 20, 2017 NeuroVive Pharmaceutical AB (Nasdaq ... positive preclinical results demonstrating anti-fibrotic effects with ... steatohepatitis (NASH), in an additional well-validated experimental ... has previously shown similar anti-fibrotic effects in ... scientists present novel data demonstrating anti-fibrotic effects ...
(Date:4/19/2017)... 19, 2017 /PRNewswire/ - CRH Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) (the ... Co. Healthcare Investor Conference 2017 at the Sheraton Hotel in ... Chief Executive Officer of the Company is scheduled to present on ... Bear and the Chairman of the Board, Tony Holler ... ...
Breaking Medicine Technology: